WO2000077026A1 - 49 human secreted proteins - Google Patents
49 human secreted proteins Download PDFInfo
- Publication number
- WO2000077026A1 WO2000077026A1 PCT/US2000/014973 US0014973W WO0077026A1 WO 2000077026 A1 WO2000077026 A1 WO 2000077026A1 US 0014973 W US0014973 W US 0014973W WO 0077026 A1 WO0077026 A1 WO 0077026A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- human
- seq
- sequence
- polypeptide
- soares
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002383041A CA2383041A1 (en) | 1999-06-11 | 2000-06-01 | 49 human secreted proteins |
AU55912/00A AU5591200A (en) | 1999-06-11 | 2000-06-01 | 49 human secreted proteins |
JP2001503883A JP2003502062A (ja) | 1999-06-11 | 2000-06-01 | 49個のヒト分泌タンパク質 |
EP00941165A EP1192176A4 (de) | 1999-06-11 | 2000-06-01 | 49 menschliche sekretierte proteine |
US10/105,299 US7368527B2 (en) | 1999-03-12 | 2002-03-26 | HADDE71 polypeptides |
US10/670,185 US20070015162A1 (en) | 1999-03-12 | 2003-09-25 | 99 human secreted proteins |
US10/670,186 US20070031842A1 (en) | 1999-03-12 | 2003-09-25 | 379 human secreted proteins |
US10/868,184 US20070048818A1 (en) | 1999-03-12 | 2004-06-16 | Human secreted proteins |
US10/994,608 US20070048297A1 (en) | 1999-03-12 | 2004-11-23 | Human secreted proteins |
US11/781,665 US20070298491A1 (en) | 1999-03-12 | 2007-07-23 | Human Secreted Proteins |
US12/753,401 US8410248B2 (en) | 1999-03-12 | 2010-04-02 | HWBAO62 polypeptides |
US13/848,789 US20130203164A1 (en) | 1999-03-12 | 2013-03-22 | Human Secreted Proteins |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13863099P | 1999-06-11 | 1999-06-11 | |
US60/138,630 | 1999-06-11 |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/014928 Continuation-In-Part WO2000077237A1 (en) | 1999-03-12 | 2000-06-01 | 49 human secreted proteins |
PCT/US2000/014964 Continuation-In-Part WO2000077023A1 (en) | 1999-03-12 | 2000-06-01 | 48 human secreted proteins |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/014928 Continuation-In-Part WO2000077237A1 (en) | 1999-03-12 | 2000-06-01 | 49 human secreted proteins |
PCT/US2000/014964 Continuation-In-Part WO2000077023A1 (en) | 1999-03-12 | 2000-06-01 | 48 human secreted proteins |
US95008301A Continuation-In-Part | 1999-03-12 | 2001-09-12 | |
US95008201A Continuation-In-Part | 1999-03-12 | 2001-09-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000077026A1 true WO2000077026A1 (en) | 2000-12-21 |
WO2000077026A8 WO2000077026A8 (en) | 2001-03-29 |
Family
ID=22482899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/014973 WO2000077026A1 (en) | 1999-03-12 | 2000-06-01 | 49 human secreted proteins |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1192176A4 (de) |
JP (1) | JP2003502062A (de) |
AU (1) | AU5591200A (de) |
CA (1) | CA2383041A1 (de) |
WO (1) | WO2000077026A1 (de) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002024913A2 (en) * | 2000-09-25 | 2002-03-28 | Millennium Pharmaceuticals, Inc. | 32612, a novel human peptide transporter and uses therefor |
WO2002033096A2 (en) * | 2000-10-16 | 2002-04-25 | Bayer Aktiengesellschaft | Regulation of human serine-threonine protein kinase |
US6710170B2 (en) | 1999-09-10 | 2004-03-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
EP1489095A1 (de) * | 2000-06-02 | 2004-12-22 | Genentech Inc. | Polypeptide, dafür kodierende Nukleinsäuren, und deren Verwendung zur Diagnose von Krebs |
US7144990B2 (en) | 2001-06-01 | 2006-12-05 | Genentech, Inc. | Antibody to a polypeptide overexpressed in tumors |
WO2008103962A3 (en) * | 2007-02-22 | 2008-12-18 | Genentech Inc | Methods for detecting inflammatory bowel disease |
US7598051B2 (en) | 1999-09-10 | 2009-10-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
US8183347B2 (en) | 2006-03-17 | 2012-05-22 | Genentech, Inc. | Anti-TAT226 antibodies and immunoconjugates |
RU2532228C2 (ru) * | 2009-01-21 | 2014-10-27 | Массачусетс Инститьют Оф Текнолоджи | Композиции и способы, используемые для оценки цитотоксичности отдельных клеток |
US20150071905A1 (en) * | 2012-01-17 | 2015-03-12 | The Board Of Trustees Of The Leland Stanford Junior University | High Affinity Sirp-Alpha Reagents |
US10125183B2 (en) * | 2015-06-29 | 2018-11-13 | Curacle Co., Ltd. | Decoy peptides inhibiting binding of AMIGO2 and 3-phosphoinositide-dependent kinase 1 |
CN109030796A (zh) * | 2018-06-26 | 2018-12-18 | 山东卓越生物技术股份有限公司 | 医疗测试卡片及其测试装置 |
US10259859B2 (en) | 2015-08-07 | 2019-04-16 | ALX Oncology Inc. | Constructs having a SIRP-α domain or variant thereof |
US11613564B2 (en) | 2019-05-31 | 2023-03-28 | ALX Oncology Inc. | Methods of treating cancer |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7193058B2 (ja) * | 2018-08-08 | 2022-12-20 | イミューンオンコ バイオファーマシューティカルズ (シャンハイ) インコーポレイテッド | Cd47およびher2を標的とする組換え二機能性タンパク質 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045437A2 (en) * | 1997-04-10 | 1998-10-15 | Genetics Institute, Inc. | SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2291260A1 (en) * | 1997-06-06 | 1998-12-10 | Human Genome Sciences, Inc. | 207 human secreted proteins |
-
2000
- 2000-06-01 CA CA002383041A patent/CA2383041A1/en not_active Abandoned
- 2000-06-01 JP JP2001503883A patent/JP2003502062A/ja not_active Withdrawn
- 2000-06-01 AU AU55912/00A patent/AU5591200A/en not_active Abandoned
- 2000-06-01 WO PCT/US2000/014973 patent/WO2000077026A1/en not_active Application Discontinuation
- 2000-06-01 EP EP00941165A patent/EP1192176A4/de not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045437A2 (en) * | 1997-04-10 | 1998-10-15 | Genetics Institute, Inc. | SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
Non-Patent Citations (5)
Title |
---|
DATABASE GENBANK [online] 18 December 1997 (1997-12-18), "especially bases 1-622", XP002908797, Database accession no. AA780275 * |
DATABASE GENBANK [online] June 1999 (1999-06-01), "especially bases 1-243", XP002938803, Database accession no. Q9Y4S1 * |
DATABASE GENEMBL [online] 16 June 1999 (1999-06-16), "especially bases 6-2153", XP002938801, Database accession no. AL080121 * |
DATABASE GENEMBL [online] 28 August 1999 (1999-08-28), "especially bases 150598-151904", XP002938802, Database accession no. AC009675 * |
See also references of EP1192176A4 * |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7598051B2 (en) | 1999-09-10 | 2009-10-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
US6710170B2 (en) | 1999-09-10 | 2004-03-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
US7985843B2 (en) | 1999-09-10 | 2011-07-26 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
EP1489095A1 (de) * | 2000-06-02 | 2004-12-22 | Genentech Inc. | Polypeptide, dafür kodierende Nukleinsäuren, und deren Verwendung zur Diagnose von Krebs |
WO2002024913A3 (en) * | 2000-09-25 | 2003-05-15 | Millennium Pharm Inc | 32612, a novel human peptide transporter and uses therefor |
WO2002024913A2 (en) * | 2000-09-25 | 2002-03-28 | Millennium Pharmaceuticals, Inc. | 32612, a novel human peptide transporter and uses therefor |
WO2002033096A2 (en) * | 2000-10-16 | 2002-04-25 | Bayer Aktiengesellschaft | Regulation of human serine-threonine protein kinase |
WO2002033096A3 (en) * | 2000-10-16 | 2002-09-19 | Bayer Ag | Regulation of human serine-threonine protein kinase |
US7150976B2 (en) | 2000-10-16 | 2006-12-19 | Bayer Healthcare Ag | Regulation of human serine-threonine protein kinase |
US7157558B2 (en) | 2001-06-01 | 2007-01-02 | Genentech, Inc. | Polypeptide encoded by a polynucleotide overexpresses in tumors |
US7144990B2 (en) | 2001-06-01 | 2006-12-05 | Genentech, Inc. | Antibody to a polypeptide overexpressed in tumors |
US7476723B2 (en) | 2001-06-01 | 2009-01-13 | Genentech, Inc. | Immunoconjugates and antibodies to PRO9917 |
US7208316B2 (en) | 2001-06-01 | 2007-04-24 | Genentech, Inc. | Polynucleotide overexpressed in tumors |
US7807385B2 (en) | 2001-06-01 | 2010-10-05 | Genentech, Inc. | Method of detecting PRO9917 |
USRE41888E1 (en) | 2001-06-01 | 2010-10-26 | Genentech, Inc. | Polynucleotide overexpressed in tumors |
US8183347B2 (en) | 2006-03-17 | 2012-05-22 | Genentech, Inc. | Anti-TAT226 antibodies and immunoconjugates |
US9109035B2 (en) | 2006-03-17 | 2015-08-18 | Genentech, Inc. | Anti-TAT226 antibodies and immunoconjugates |
US9675707B2 (en) | 2006-03-17 | 2017-06-13 | Genentech, Inc. | Anti-TAT226 antibodies and immunoconjugates |
US7875431B2 (en) | 2007-02-22 | 2011-01-25 | Genentech, Inc. | Methods for detecting inflammatory bowel disease |
CN101663407B (zh) * | 2007-02-22 | 2017-08-08 | 健泰科生物技术公司 | 用于检测炎性肠病的方法 |
EP2436781A1 (de) * | 2007-02-22 | 2012-04-04 | Genentech, Inc. | Verfahren für den Nachweis von entzündlicher Darmerkrankung |
US8257923B2 (en) | 2007-02-22 | 2012-09-04 | Genetech, Inc. | Methods for detecting inflammatory bowel disease |
RU2502806C2 (ru) * | 2007-02-22 | 2013-12-27 | Дженентек, Инк. | Способы выявления воспалительного заболевания кишечника |
WO2008103962A3 (en) * | 2007-02-22 | 2008-12-18 | Genentech Inc | Methods for detecting inflammatory bowel disease |
RU2532228C2 (ru) * | 2009-01-21 | 2014-10-27 | Массачусетс Инститьют Оф Текнолоджи | Композиции и способы, используемые для оценки цитотоксичности отдельных клеток |
US20150071905A1 (en) * | 2012-01-17 | 2015-03-12 | The Board Of Trustees Of The Leland Stanford Junior University | High Affinity Sirp-Alpha Reagents |
US9944911B2 (en) * | 2012-01-17 | 2018-04-17 | The Board Of Trustees Of The Leland Stanford Junior University | High affinity Sirp-alpha reagents and methods of using |
US11208481B2 (en) | 2012-01-17 | 2021-12-28 | The Board Of Trustees Of The Leland Stanford Junior University | High affinity SIRP-alpha reagents and methods of using |
US10125183B2 (en) * | 2015-06-29 | 2018-11-13 | Curacle Co., Ltd. | Decoy peptides inhibiting binding of AMIGO2 and 3-phosphoinositide-dependent kinase 1 |
US10259859B2 (en) | 2015-08-07 | 2019-04-16 | ALX Oncology Inc. | Constructs having a SIRP-α domain or variant thereof |
US10696730B2 (en) | 2015-08-07 | 2020-06-30 | ALX Oncology Inc. | Constructs having a SIRP-alpha domain or variant thereof |
US11208459B2 (en) | 2015-08-07 | 2021-12-28 | ALX Oncology Inc. | Constructs having a SIRP-alpha domain or variant thereof |
US11639376B2 (en) | 2015-08-07 | 2023-05-02 | ALX Oncology Inc. | Constructs having a SIRP-α domain or variant thereof |
CN109030796A (zh) * | 2018-06-26 | 2018-12-18 | 山东卓越生物技术股份有限公司 | 医疗测试卡片及其测试装置 |
US11613564B2 (en) | 2019-05-31 | 2023-03-28 | ALX Oncology Inc. | Methods of treating cancer |
Also Published As
Publication number | Publication date |
---|---|
CA2383041A1 (en) | 2000-12-21 |
AU5591200A (en) | 2001-01-02 |
JP2003502062A (ja) | 2003-01-21 |
EP1192176A1 (de) | 2002-04-03 |
EP1192176A4 (de) | 2003-03-05 |
WO2000077026A8 (en) | 2001-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000077026A1 (en) | 49 human secreted proteins | |
WO2000077256A1 (en) | 48 human secreted proteins | |
EP1175439A1 (de) | 49 humane sekretierte proteine | |
EP1189917A1 (de) | 48 menschliche sekretierte proteine | |
EP1173477A1 (de) | 49 humane sekretierte Proteine | |
EP1185284A1 (de) | 47 menschliche sekretierte proteine | |
EP1173462A1 (de) | 50 menschlische sekretierte hormone | |
WO2000061624A1 (en) | 48 human secreted proteins | |
EP1192249A1 (de) | 47 menschliche sekretierte proteine | |
EP1185285A1 (de) | 49 humane sekretierte proteine | |
EP1181303A1 (de) | 50 human-ausgeschiedene proteine | |
WO2000056755A1 (en) | 49 human secreted proteins | |
EP1192171A1 (de) | 48 menschliche sekretierte proteine | |
EP1187908A1 (de) | 42 humane sekretierte proteine | |
EP1185700A1 (de) | 49 menschliche sekretierte proteine | |
WO2000061625A1 (en) | 48 human secreted proteins | |
WO2000061748A1 (en) | 48 human secreted proteins | |
EP1165590A1 (de) | 49 menschliche sekretierte proteine | |
WO2000077237A1 (en) | 49 human secreted proteins | |
WO2000061627A1 (en) | 49 human secreted proteins | |
EP1177214A1 (de) | 49 menschliche sekretierte gene | |
EP1163332A1 (de) | 48 menschliche, ausgeschiedene proteine | |
EP1175503A1 (de) | 49 humane sekretierte proteine | |
EP1171590A1 (de) | 50 menschliche, sekretierte proteine | |
WO2000058340A2 (en) | 50 human secreted proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 51/2000 UNDER (51) REPLACE "C07K 2/06" BY "C07K 2/00" AND REPLACE "C07H 21/06" BY "C07H21/00" |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 503883 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2383041 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000941165 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000941165 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000941165 Country of ref document: EP |